Read news as it happens
Create a Rediffmail account
Get Rediff News delivered into your Inbox daily
Aurbindo Pharma ranks 2nd among Indian's pharma cos
With sales of over Rs 12,240 crore in nine months of the current financial year, it is ahead of Rs 11,580 crore...
Surge pricing: Ola, Uber to come under CCI lens
A surge in taxi fares earlier led Maharashtra govt to set up committee to recommend prices for these players
How desi brothers built a $1.8 bn drug co
Amneal Pharmaceuticals is set to pip Sun Pharma as the fifth largest generics maker in the US, reports Sohini Das.
After 15 years, Ranjit Shahani steps down as Novartis' India chief
The face of MNC drug firms in India and champion of IPR protection, he oversaw the Swiss giant's India expansion, its...
David vs Goliath: How Wockhardt plans to beat global challenge
Only 11 antibiotics in clinical trials have received qualified infectious disease product status from the US FDA, of...
Bansal pay issue: Kiran Mazumdar-Shaw appeals for a closure
The settlement with Sebi was seen as Infosys admitting guilt of the lapse, clearing out any legal or regulatory...
Cancer, heart condition drugs to get cheaper following price cap
According to highly placed sources in NPPA, the reduction in prices following the latest exercise will range between...
The future belongs to biopharma. Can India catch up with China?
If we are to realise the full potential of biologics' ability to improve people's health, it is essential to...
Infy seeks Sebi help over Bansal's Rs 17.38 cr severance pay
Analysts say IT major cleaning up act before new CEO takes over; regulator might take a year
Why India is key to Philips' transformation
India serves as the company's R&D hub as it morphs into a health tech major.
Office email App
© 2018 Rediff.com